CRISPR Shreds Undruggable Cancer Cells with Precision (opens in new tab)

Covers Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding

“Guardian of the genome,” p53 is now therapeutically accessible using CRISPR-based technology from Jennifer Doudna’s lab. The approach uses RNA signatures to identify and destroy traditionally undruggable cancer cells. The post appeared first on .

Read the original article